These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19549121)

  • 21. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
    Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
    J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ["... The better to see you with"--phothodynamic diagnostic in superficial bladder cancer].
    Forster TH; Wyler S; Ruszat R; Gasser TC; Bachmann A
    Praxis (Bern 1994); 2007 Oct; 96(42):1631-7. PubMed ID: 17974123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.
    Zaak D; Frimberger D; Stepp H; Wagner S; Baumgartner R; Schneede P; Siebels M; Knüchel R; Kriegmair M; Hofstetter A
    J Urol; 2001 Nov; 166(5):1665-8; discussion 1668-9. PubMed ID: 11586198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
    Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
    J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
    Burger M; Stief CG; Zaak D; Stenzl A; Wieland WF; Jocham D; Otto W; Denzinger S
    Urology; 2009 Dec; 74(6):1282-6. PubMed ID: 19819538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hexyl aminolevulinate fluorescence cystoscopy in bladder cancer.
    Sievert KD; Kruck S
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1055-63. PubMed ID: 19671025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
    Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A
    J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.
    Witjes JA; Douglass J
    Nat Clin Pract Urol; 2007 Oct; 4(10):542-9. PubMed ID: 17921969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer].
    Daniltchenko D; Riedl C; Koenig F; Daha LK; Sachs M; Schnorr D
    Aktuelle Urol; 2004 Nov; 35(6):497-501. PubMed ID: 15526230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel endoscopic diagnosis for bladder cancer.
    Lerner SP; Goh A
    Cancer; 2015 Jan; 121(2):169-78. PubMed ID: 25132313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
    Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
    Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
    Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
    Urologiia; 2004; (6):37-40. PubMed ID: 15719729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid.
    Drăgoescu O; Tomescu P; Pănuş A; Enache M; Maria C; Stoica L; Pleşea IE
    Rom J Morphol Embryol; 2011; 52(1):123-7. PubMed ID: 21424043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations.
    Witjes JA; Redorta JP; Jacqmin D; Sofras F; Malmström PU; Riedl C; Jocham D; Conti G; Montorsi F; Arentsen HC; Zaak D; Mostafid AH; Babjuk M
    Eur Urol; 2010 Apr; 57(4):607-14. PubMed ID: 20116164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.
    Nakai Y; Inoue K; Tsuzuki T; Shimamoto T; Shuin T; Nagao K; Matsuyama H; Oyama M; Furuse H; Ozono S; Miyake M; Fujimoto K
    Int J Urol; 2018 Aug; 25(8):723-729. PubMed ID: 29999205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
    Burger M; Grossman HB; Droller M; Schmidbauer J; Hermann G; Drăgoescu O; Ray E; Fradet Y; Karl A; Burgués JP; Witjes JA; Stenzl A; Jichlinski P; Jocham D
    Eur Urol; 2013 Nov; 64(5):846-54. PubMed ID: 23602406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
    Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
    Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence diagnosis of bladder cancer.
    Chatterton K; Ray E; O'Brien TS
    Br J Nurs; 2006 Jun 8-21; 15(11):595-7. PubMed ID: 16835527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Editorial comment on Stepp H. et al.: fluorescence diagnosis and photodynamic therapy in urology].
    Jocham D
    Aktuelle Urol; 2007 Nov; 38(6):453-4. PubMed ID: 17987532
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fluorescent diagnostics of urinary bladder cancer].
    Lopatkin NA; Kamalov AA; Kudriavtsev IuV; Tokarev FV
    Urologiia; 2000; (4):3-6. PubMed ID: 11186690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.